The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes.
アテローム生成的な食後の残りのかけらのビルダグリプチン治療の効果と2型糖尿病の被験者におけるLDL粒径。
Published date
Affiliation
Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland; Division of Cardiology, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
Abstract
